Hifer

Quick links to important sections

Hifer

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hifer

Quick Facts

Property Description
Active ingredient Elemental Iron (as Ferrous or Ferric salt)
Form Oral preparation (Tablet or Capsule)
Pharmacological class Anti-anemic agent, Iron replacement product
General purpose Supports hemoglobin synthesis
Origin Derived Essential mineral

Hifer: Definition and Pharmacological Classification

Hifer is a pharmaceutical preparation classified as an Iron replacement product and an Anti-anemic agent. Its core function is to supply the essential mineral Elemental Iron to the body, addressing states of iron imbalance. It is categorized among Hematopoietic agents, which are used to support the formation of blood components. Iron plays a central role in supporting red blood cell health and maintaining systemic iron levels.

Composition and Form of Elemental Iron

The active ingredient in Hifer is Elemental Iron, typically delivered as a specific ferrous salt or ferric form, and is manufactured as an oral preparation. The iron salt is processed into solid dosage forms, like a tablet or capsule, designed for systemic absorption. Iron is an essential mineral that is a necessary component for the synthesis of hemoglobin. Iron preparations are primarily used to manage iron deficiency by promoting the formation of red blood cells, which enables the blood to transport oxygen throughout the body. Hifer is characterized by its specific salt formulation and excipient base, designed to balance effective Iron absorption with patient tolerability.

General Therapeutic Purpose

The general therapeutic purpose of Hifer is to counteract iron deficiency by supplying the necessary substrate for continuous hemoglobin synthesis. The absorbed Elemental Iron facilitates efficient oxygen transport throughout the circulatory system, a mechanism necessary for cellular energy production. This erythropoiesis support is intended to assist in addressing the persistent fatigue and compromised vitality often associated with low iron levels.

Regulatory References

  1. NIH Office of Dietary Supplements Iron Fact Sheet
  2. MedlinePlus Drug Information: Iron Supplements

What side effects are possible with Hifer?

Possible Side Effects and Safety Information

The safety profile for oral iron preparations like Hifer is primarily defined by effects on the Gastrointestinal System and specific regulatory warnings regarding toxicity. These adverse reactions are classified based on frequency as documented in official regulatory sources, such as FDA and SmPC documents.

Frequency-Classified Adverse Reactions

Classification System-Organ Class Reported Adverse Reaction(s)
Common Gastrointestinal Disorders Nausea, vomiting, diarrhea, constipation, stomach pain/cramps, abdominal discomfort.
Expected Gastrointestinal Disorders Darkening or black stools, which is a known effect of iron absorption.
Rare Immune System Disorders Hypersensitivity reactions, including reports of rash and anaphylaxis.

Serious Safety Considerations

Accidental Overdose of iron-containing products is specifically listed in official labeling as a leading cause of fatal poisoning in children under six years of age, necessitating a Boxed Warning on the product. Symptoms of severe overdose involve lethargy, severe vomiting, bloody diarrhea, and potentially circulatory collapse.

Safety-Related Restrictions

Regulatory documents emphasize that Hifer is contraindicated in patients with established iron overload syndromes, such as hemochromatosis or hemosiderosis. It should not be used in the management of anaemias that are not caused by iron deficiency. Gastrointestinal side effects may be minimized by consuming the product with or after food, which establishes a time-related safety pattern linked to the context of administration.

Overdose and Emergency Response

Overdose and when to seek help

Accidental overdose of iron-containing products, including Hifer, is a leading cause of fatal poisoning in children under 6 years of age. Regulatory documentation mandates that this product be kept out of reach of children and that emergency medical help be sought immediately upon suspected ingestion.

Documented Manifestations and Severe Outcomes

An overdose may initially present with severe corrosive gastrointestinal toxicity, including abdominal pain, vomiting, diarrhea, and potentially hematemesis (vomiting blood) or bloody stools. In severe cases, symptoms can progress to a life-threatening systemic collapse marked by circulatory shock, metabolic acidosis, seizures, and coma. Delayed but severe outcomes documented in regulatory sources include acute liver failure and gastrointestinal obstruction due to scarring.

Required Emergency Actions

In case of accidental overdose, the official regulatory instruction is to call a doctor or Poison Control Center immediately. Urgent medical services (e.g., 911) must be contacted if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Treatment in a hospital setting often requires continuous monitoring of vital signs and serum iron levels, and may involve administration of the specific chelating agent Deferoxamine.

Therapeutic Uses of Hifer

What Hifer Treats: Main Uses and Benefits

Hifer is an iron replacement product used to manage conditions related to low iron levels. This medication serves to provide iron to the body, supporting the management of iron levels when dietary intake alone may be insufficient.

Hifer is commonly used to help with conditions characterized by periods of heightened symptoms, including Iron Deficiency Anemia (IDA) and non-anemic iron deficiency. The core therapeutic benefit is relevant in contexts involving heightened systemic burden, which is helpful for easing symptoms that interfere with daily functioning.

The medication is applied in addressing symptoms that create noticeable physiological strain, such as persistent fatigue, generalized weakness, shortness of breath upon exertion, and issues like poor concentration. It is also commonly used in clinical scenarios characterized by high iron demand or chronic loss, notably for pregnant women and individuals with heavy menstrual bleeding, providing support that assists with maintaining functional stability.

Quick Fact: Symptom Management
Symptom Domain Energy and Physical Capacity Deficits
Use Context Chronic iron loss or high physiological demand
Patient Benefit Supports easing the overall symptom burden, assists with managing symptoms that create noticeable physiological strain and supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Hifer

This section describes the populations permitted and prohibited from using Hifer (Oral Elemental Iron) based strictly on governmental regulatory documents.

Contraindicated Populations (Must Not Use)
Patients diagnosed with Hemochromatosis or other Iron Overload Syndromes
Patients receiving repeated blood transfusions
Individuals with a known hypersensitivity to the active substance (Elemental Iron)
Patients with active Peptic Ulceration, Ulcerative Colitis, or Regional Enteritis

Age-Specific Eligibility Rules

  • Adults are the standard population for therapeutic use.
  • Children: Use in children requires medical consultation. Regulators issue a mandatory warning that accidental overdose is a leading cause of fatal poisoning in children under 6.
  • Older Adults: No specific dose adjustment is typically required, and use is generally permitted under standard conditions.

Condition-Based and Restricted Use

  • Use should be avoided in patients currently experiencing an active Inflammatory Bowel Disease (IBD) flare.
  • The medicine is permitted for use in pregnant and lactating women when clinically indicated for iron deficiency management.

Connection to the overall eligibility profile: Regulatory documents define eligibility by establishing mandatory exclusions based on two primary constraints: pre-existing iron accumulation risk (e.g., Hemochromatosis) and active damage to the gastrointestinal tract (e.g., Peptic Ulceration). The profile strictly dictates who is permitted to use the medicine and who is formally excluded, without providing clinical advice.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Hifer (oral elemental iron) is primarily defined by pharmacokinetic interactions that reduce the absorption of co-administered substances. This effect is caused by binding or chelation in the gastrointestinal tract, leading to decreased systemic exposure of the interacting medicine.


Official Interaction Statements

  • Mandatory Timing Separation: Administration of Hifer and most interacting oral medications, including Tetracycline and Fluoroquinolone antibiotics, Levothyroxine, and Bisphosphonates, must be separated. This rule, specified in regulatory documents, aims to mitigate the clinically significant reduction in bioavailability of the co-administered drug.
  • Contraindicated Combinations: The concurrent use of an oral iron preparation like Hifer with parenteral (injectable) iron preparations is contraindicated by official labeling due to the risk of iron overload.
  • Reduced Drug Exposure: Hifer is documented to reduce the absorption of other medicines, including Levodopa, Methyldopa, and Mycophenolate, a pattern that necessitates timed administration separation to preserve therapeutic levels.
  • Food and Supplement Interaction: The presence of certain foods, such as those high in calcium (dairy products) or high-fiber products, along with supplements containing zinc or antacids, is officially documented to reduce the absorption of the elemental iron from Hifer. For optimal absorption, administration should be separated from these substances.

Connection to the Overall Interaction Profile

Regulatory documents establish that Hifer’s interaction structure is dominated by its tendency to bind other compounds in the digestive system, resulting in reduced exposure for multiple medicine classes. This interaction pattern requires a mandatory timing rule where Hifer and interacting medicines must be administered hours apart. The profile also includes an explicit restriction on co-administration with injectable iron products, which is classified as a contraindication.

Mechanism of Action

Essential Iron Replenishment and Cofactor Activity

Hifer provides elemental iron, which is primarily absorbed across the intestinal epithelium via the DMT1 transporter and then released into the systemic circulation by ferroportin. The iron binds to the transport protein transferrin for delivery to the bone marrow. Within erythroid precursors, iron is incorporated into protoporphyrin to form heme, a necessary component of hemoglobin molecules. The formulation also delivers Folic Acid (Vitamin B9), which functions as a critical co-factor in one-carbon metabolism. Folic Acid is essential for the synthesis of purines and pyrimidines, which are the building blocks of DNA. This mechanism supports the proliferation and differentiation of erythroid progenitor cells, a process required for the production of viable erythrocytes. The combination ensures both the molecular substrate (iron) and the necessary co-factor (folate) are available to support the terminal stages of the erythropoietic pathway.

Dosage and Administration Information

Hifer is an oral preparation administered as a tablet, capsule, or liquid solution. The standard route of administration is strictly oral. The usage regimen is defined by the amount of Elemental Iron supplied, not the salt weight. For the treatment of deficiency, the typical adult dosing regimen is 100 mg to 200 mg of Elemental Iron per day, which is usually administered in divided doses.

To promote optimal absorption, the medicine is preferably taken on an empty stomach, such as one hour before or two hours after a meal. However, the dose may be taken with or after meals to minimize gastrointestinal discomfort and improve tolerance. Specific handling instructions require that tablets, particularly delayed-release forms, must be swallowed whole with water and must not be sucked, crushed, or chewed. Liquid forms should be measured accurately and consumed using a straw to prevent potential tooth staining.

The course duration is typically long-term, often lasting for six to eight weeks to correct anemia and up to six months to fully replenish the body's iron stores. A key procedural constraint is the requirement to separate Hifer from certain other medications, such as oral tetracycline antibiotics and levothyroxine, by at least two hours, as iron can interfere with their absorption. Pediatric dosing for children under 12 years is not standardized on the label and requires consultation with a physician. If a dose is missed, the standard protocol is to take only the next dose at the regularly scheduled time.

Recent Clinical Evidence

Hifer: Recent Clinical Evidence

Hifer is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have chronic kidney disease (CKD) and are receiving hemodialysis. The body of research supporting Hifer focuses on its efficacy in raising and maintaining key iron-related markers, which are critical for managing this condition.

Efficacy in Iron Repletion

Clinical studies have demonstrated that Hifer is associated with increases in transferrin saturation (TSAT) and serum ferritin (SF) levels. These markers are widely used to assess the body’s iron stores and the availability of iron for red blood cell production. In trials involving adult patients with iron deficiency anemia on hemodialysis, the use of Hifer was observed to achieve target TSAT and SF levels in a percentage of participants. The time required to achieve iron repletion levels was generally consistent with the protocol of the clinical trials.

Clinical Endpoint Research Observation (General Summary)
Transferrin Saturation (TSAT) Observed increases in TSAT, suggesting improved iron availability for erythropoiesis.
Serum Ferritin (SF) Associated with increases in SF, reflecting a replenishment of stored iron in the body.

Impact on Hemoglobin Levels

While Hifer is designed to address iron stores, a secondary observation from studies relates to its indirect impact on hemoglobin (Hb) levels. Hemoglobin is the protein in red blood cells that carries oxygen, and low levels define anemia. Research indicates that the use of Hifer, as part of an anemia management regimen, may support the maintenance or increase of Hb levels. This effect is thought to occur through the provision of essential iron for the body to produce new red blood cells. Hifer is not a replacement for erythropoiesis-stimulating agents (ESAs) but is studied for its role in optimizing iron levels to allow ESAs to work effectively.

Frequently Asked Questions (FAQ)

Common questions about Hifer (FAQ)

Q: Is Hifer available without a prescription?

Official information indicates that oral iron products are available in various forms, including both over-the-counter (OTC) supplements and prescription-only medications (Rx). The regulatory status often depends on the specific concentration of elemental iron in the product. Information regarding the regulatory status of a specific product is typically found on the product label or discussed with a healthcare provider.


Q: Can Hifer be used by people with other long-term health issues?

Regulatory documents list specific long-term health issues where the medicine should not be used, known as contraindications. Examples include disorders that cause iron overload, such as hemochromatosis, or active gastrointestinal issues like inflammatory bowel disease. Official sources emphasize that a healthcare professional must review existing health conditions prior to initiating use.


Q: Is Hifer a type of antibiotic or pain reliever?

No. Official drug classification systems identify Hifer as an Anti-anemic agent and an Iron replacement product. Its sole function is to supply elemental iron to the body, supporting the creation of red blood cells, rather than treating infections or managing pain.


Q: Can Hifer interact with common vitamins or supplements?

Yes, official product information indicates that Hifer can interact with certain supplements by reducing its own absorption. Specifically, supplements containing elements like zinc and antacids can interfere with the way the body takes in iron. The interaction profile notes that administration of Hifer and these substances must often be separated by time to mitigate interference.


Q: What does 'contraindication' mean in relation to Hifer?

A contraindication is a condition or circumstance that makes the use of a medicine medically improper because it may cause harm. Regulatory documents state that for Hifer, contraindications include pre-existing iron overload conditions like hemochromatosis or active inflammation of the gastrointestinal tract, such as peptic ulceration.


Q: Is it normal to feel tired after starting Hifer?

Tiredness, or fatigue, is a common and primary symptom of iron deficiency, which is the condition Hifer is prescribed to treat. While regulatory tables do not typically list fatigue as an adverse reaction of the medicine itself, as Hifer is intended to address the underlying iron deficiency, research indicates that iron-related markers typically increase over time.


Q: Does Hifer cause changes in mood or sleep?

Changes in mood or sleep are generally not listed among the common or expected adverse reactions for oral iron preparations in official regulatory tables. The documented side effects mainly focus on the gastrointestinal system, such as nausea and constipation.


Q: Why do some patient forums talk about a change in appetite with Hifer?

Official adverse reaction lists for oral iron products sometimes include anorexia, which is a loss of appetite, as a possible reaction. This may be related to the more commonly reported gastrointestinal side effects like nausea or stomach discomfort.


Q: Is there a generic version of Hifer available?

Yes. The active ingredient in Hifer, Elemental Iron (delivered in various salt forms), is widely available and marketed under many different generic names. Hifer is the specific brand name for one such pharmaceutical preparation.


Q: Does Hifer affect the results of any common lab tests?

Hifer is specifically intended to affect certain lab tests, as its purpose is to increase key blood markers. These markers include transferrin saturation (TSAT) and serum ferritin (SF), which are used by healthcare professionals to measure and monitor the body's iron levels and storage capacity.


Q: How long does Hifer stay in the body after I stop taking it?

Iron from Hifer is not eliminated quickly like many typical medicines. Instead, it is absorbed and used to replenish the body’s iron stores and hemoglobin. Therefore, the effects of the treatment are long-lasting, and the iron is integrated into the body's necessary biological components.


Q: Does Hifer have a risk of dependence or addiction?

No. Official governmental classifications confirm that Hifer, as an oral elemental iron product, is not classified as a controlled substance and carries no official risk of dependence or addiction.


Q: Why is Hifer sometimes described as a 'first-line treatment'?

Oral iron preparations are often described in clinical guidelines, which are based on regulatory standards, as the first-line therapy for treating uncomplicated iron deficiency anemia. This is due to their established efficacy and favorable patient-management profile in most cases.


Q: What should I do if the side effects of Hifer seem too strong?

Official patient information advises that common GI side effects can sometimes be reduced by taking the dose with or after food. Regulatory documents state that any serious or severe adverse reactions, such as symptoms related to overdose or hypersensitivity (e.g., rash), are to be reported to a healthcare professional.


Q: Can Hifer interact with herbal remedies like St. John's Wort?

Regulatory documents outline that Hifer's iron component can bind to and reduce the absorption of other compounds in the digestive system. While specific herbal remedies may not be listed, it is a general principle that any substance that affects absorption may interact. The full interaction profile, including the use of herbal remedies, is typically reviewed by a healthcare professional prior to starting treatment.


Q: What are the general rules for stopping Hifer once the treatment is finished?

Regulatory guidance specifies that treatment duration is often prolonged to ensure full iron repletion. Specifically, the medicine is typically continued for a period of up to six months after the patient’s hemoglobin levels have returned to normal to fully replenish the body's stored iron.


Q: Are there any known long-term safety concerns with Hifer?

The main long-term safety concern addressed in official documents is the risk of iron overload, which can occur with prolonged use without monitoring. For this reason, official sources advise periodic monitoring of a patient's iron status to prevent accumulation and related harm.


Q: Is Hifer considered a high-alert medication?

Regulatory bodies issue a Boxed Warning that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years of age. This critical safety alert mandates strict storage requirements to keep the medicine out of sight and reach of children.


Q: What are the eligibility criteria for being prescribed Hifer?

Hifer is officially indicated for the treatment of iron deficiency anemia. Eligibility is further defined by exclusion criteria, or contraindications, which prohibit use in patients with conditions like iron overload or active inflammatory gastrointestinal diseases.


Q: Are headaches a commonly reported side effect of Hifer?

Headaches are not listed among the common adverse reactions detailed in official regulatory tables for this oral iron product. The documented common side effects primarily involve the gastrointestinal system, such as nausea, constipation, and stomach discomfort.


Q: Does Hifer require regular blood monitoring?

Yes. Regulatory guidelines advise that the patient's blood parameters, particularly hemoglobin (Hb) levels and indicators of iron stores, should be monitored periodically. This monitoring is necessary to ensure the patient is responding appropriately to treatment and to prevent the risk of iron accumulation.


Q: Is Hifer a controlled substance?

No, official regulatory bodies confirm that Hifer, like other oral elemental iron products, is not classified as a controlled substance under drug enforcement schedules.


Q: Are there any specific genetic factors that affect how Hifer works?

Official documents list hemochromatosis as a contraindication. This is an inherited disorder that causes the body to absorb too much iron. While it affects eligibility, the drug’s general mechanism of action (absorption) is universal.


Q: Does Hifer affect fertility in men or women?

There are typically no official statements regarding the effect of elemental iron on fertility. However, official information confirms the medicine is generally permitted for use in pregnant and lactating women when treating iron deficiency.

How should Hifer be stored and disposed of?

How to Store and Dispose of Hifer

The storage of Hifer (Oral Iron Preparation) is defined by regulatory standards to maintain product quality and ensure safety.

Storage Requirements

Hifer must be stored at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F). The product must be kept in a dry place and protected from excessive heat and moisture. To ensure stability, the medication should remain in its original container with the lid tightly closed.

Child-Safety and Disposal

It is a mandatory requirement that Hifer be kept out of sight and reach of children due to the high risk of fatal iron poisoning. Unused or expired Hifer should be disposed of through a drug take-back program. If a program is unavailable, the product must be mixed with an unappealing substance, sealed in a bag, and discarded in the household trash; do not flush the medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Hifer found in:

A-Z Index: